Registration Desk Hours: 8:30 AM – 4:30 PM

8:30 AM – Breakfast

9:30 AM – 11:00 AM – Understanding Lymphoma and Chronic Lymphocytic Leukemia (CLL): Current Perspectives

Lymphoma and CLL Overview – Eduardo Sotomayor, MD, Tampa General Hospital
This session will focus on an overview of lymphoma, including the different types of lymphoma and chronic lymphocytic leukemia.

Beyond Chemotherapy: Emerging Treatment Options – Peter Martin, MD, Weill Cornell Medicine
The lymphoma/CLL treatment landscape is changing rapidly. Learn about targeted therapies such as BTK inhibitors, BCL-2 inhibitors, BTK degraders and others that can be used as part of your treatment toolbox..

Clinical Trials – Jennifer Amengual, MD, Colombia University Medical Center
Every drug available today had to be tested in clinical trials before it was approved for general use. Learn more about clinical trials and the impact these studies will have for the future of lymphoma/CLL treatment.

11:00 AM – Networking Break

11:30 AM – Disease-Specific Breakout Sessions (choose one)
These sessions are an opportunity for patients and care partners to learn more about the disease biology, treatment options and clinical trials related to their specific subtype. These sessions will cover topics for newly diagnosed and relapsed/refractory patients. There will be a Question and Answer discussion at the conclusion of each presentation.

• Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma – Erin Mulvey, MD, Weill Cornell Medicine
• Diffuse Large B-Cell Lymphoma and Other Aggressive B-Cell Lymphomas – Hua-Jay J Cherng, MD, Columbia University Medical Center
• Follicular Lymphoma and Marginal Zone Lymphoma – Carla Casulo, MD, University of Rochester
• Hodgkin Lymphoma – Eduardo Sotomayor, MD, Tampa General Hospital
• Mantle Cell Lymphoma – Anita Kumar, MD, Memorial Sloan Kettering Cancer Center
• T-Cell Lymphomas (including PTCL and CTCL) – Jia Ruan, MD, Weill Cornell Medicine
• Waldenstrom Macroglobulinemia – Shayna Sarosiek, MD, Dana-Farber Cancer Institute

12:45 PM – Networking Lunch
Attendees will have the opportunity to sit at tables and network with others who have the same disease-subtype.

12:45 PM – Care Partner Lunch
Care Partners attending the program will have an opportunity to meet one of the Foundation’s Care Partner Ambassadors during their own lunch and share experiences and support.

1:45 PM – Update on Immunotherapies – Joanna Rhodes, MD, Rutgers Cancer Institute of New Jersey
Immunotherapy enhances the power of a patient’s immune system to attack tumors. Learn more about chimeric antigen receptor (CAR) T-cell therapy, bispecific antibodies, antibody-drug conjugates (ADC) checkpoint inhibitors and the other classes of immunotherapy that are either approved or under investigation for lymphoma patients.

2:45 PM – Networking Break

3:15 PM – Profile of Hope
Join us and one of our Patient Ambassadors as they share their story of being diagnosed with lymphoma and how they got involved with the Lymphoma Research Foundation.

3:30 PM – Nutrition – Peter Adintori, MS, RD, CSO, CDN, CNSC, Memorial Sloan Kettering Cancer Center
A healthy diet and good nutrition are very important before, during, and after treatment. Learn about nutritious foods that can help you stay healthy no matter where you are along your patient journey.

5:00 PM – Dinner Reception for all attendees

Registration Desk Hours: 8:00 AM – 2:00 PM

8:30 AM – Breakfast

9:15 AM – How to Work with Your Healthcare Team Panel From a Nurse’s Perspective
Moderator: Jennifer Amengual, MD, Columbia University Medical Center
Panelists: Supriya S. Vaidya, DNP, FNP-BC, Columbia University Medical Center, Maison Amori Nasser, BSN, Columbia University Medical Center

Hear from our lymphoma expert panel about issues that patients often face when given a lymphoma diagnosis and how they can be discussed with their own healthcare teams.

10:15 AM – Networking Break

10:30 AM – Special Lymphoma Topics Breakouts (choose one)

• Treatment Options for Transformed Lymphomas – Theodora Anagnostou, MD, Mount Sinai
  Transformed lymphoma occurs when an indolent lymphoma develops into a more aggressive one. Learn more about transformed lymphomas and the treatment options available when a lymphoma transforms.
• Diagnosing and Managing Lymphoma with Diagnostic and Biomarker Testing – Adam Olszewski, MD, Brown University
  There have been remarkable improvements in how cancers are detected and diagnosed, including testing cancer cells for genes and proteins that may affect which treatments might be most appropriate for a patient. Learn more about how this can be applied to the diagnosis and treatment of lymphoma/CLL.
• Surveillance Strategies – I’ve finished my treatment, what comes next? – Elise Chong, MD, University of Pennsylvania
  After patients complete their treatment, there might be different ways that they can be monitored to maintain their health. This session will describe the types of scans, bloodwork, and other tests that can be used during follow-up care.

11:30 AM – Networking Break

11:45 AM – Update on Managing COVID-19 and Post-Treatment Infections – Alexander Drelick, MD, Weill Cornell Medicine
While COVID-19 may seem to have faded from public view, it is still very relevant for blood cancer patients. Learn more about the latest COVID-19 management strategies for those living with lymphoma/CLL, as well as the importance of monitoring for other infections that can occur after treatment.

12:45 PM – Break for Lunch

1:00 PM – Lunch and Learn: Lymphoma Survivorship – Emily Tonorezos, MD, National Cancer Institute
There are an increasing number of lymphoma and CLL survivors each year. Learn more about managing long-term side effects, follow-up care and the on-going emotional impact of a lymphoma/CLL diagnosis

2:00 PM – Closing Remarks